Oncology and radiology leaders have called into question a study led by researchers at Oakland-based University of California that found personalized risk-based breast cancer screening as effective as standard annual screening guidelines. The study, published Dec. 12 in JAMA Network,…
The Latest
An investigational breast cancer vaccine produced an immune response in 74% of clinical trial participants, according to data being presented at the San Antonio Breast Cancer Symposium. Cleveland Clinic researchers conducted the phase 1 clinical trial, which enrolled 35 patients…
Patients with oropharyngeal cancer who were treated with proton therapy experienced a 91% five-year overall survival rate, compared to 81% for those who received photon therapy, according to a study published Dec. 11 in the Lancet. Eighteen health systems participated…
University of Miami Sylvester Comprehensive Cancer Center has named Tracy Crane, PhD, as the Brigitte Burke Endowed Chair for Women’s Cancer Research. Dr. Crane serves as co-leader of the center’s Cancer Control Program and its director of lifestyle medicine, prevention…
Preoperative MRI may be unnecessary for patients with stage 1 or 2 hormone receptor-negative breast cancer, according to a study from Houston-based University of Texas MD Anderson Cancer Center. The clinical trial was designed to test the assumption that utilizing…
Worcester, Mass.-based UMass Memorial Health has received approval from state regulators to build a $54 million cancer care facility that will offer proton therapy. The Massachusetts Department of Public Health and Public Health Council approved the health system’s request to…
Patients who received MRI-guided focused ultrasound during standard-of-care chemotherapy had an almost 40% increase in overall survival, according to a study published Nov. 24 in the Lancet Oncology. Led by a team from Baltimore-based University of Maryland School of Medicine,…
An AI-enabled lung nodule management program facilitated an 87% follow-up of nodules identified during CT scans, according to a study published Oct. 23 in the Journal of Thoracic Oncology. Researchers at Rochester, Minn.-based Mayo Clinic used natural language processing software…
The University of Chicago Medicine has launched a center dedicated to rare blood cancers. Led by UChicago Medicine hematologist/oncologist Michael Drazer, MD, PhD, as director, the Miller Family Center for Rare Blood Cancers began operations in July, according to a…
Providence, based in Renton, Wash., Microsoft Research and the University of Washington have developed an AI pathology model that researchers say can map how immune cells interact with tumors on a scale not previously possible. The model, called GigaTIME, was…